The Doctor’s Channel covered SHM 2010 in Washington, D.C., the annual meeting for the Society of Hospital Medicine. At SHM 2010, those associated with hospital medicine collaborate with…
NEW YORK (Reuters Health) – The nonselective beta-blocker carvedilol and the beta-1-selective beta-blockers metoprolol succinate and bisoprolol have significantly different treatment effects in patients with chronic heart failure…
NEW YORK (Reuters Health) – Clopidogrel reloading does not benefit patients undergoing percutaneous coronary intervention (PCI) who are already on chronic clopidogrel therapy, Italian researchers reported online April…
NEW YORK (Reuters Health) – Anemia increases the risk of bleeding and death after percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), a new study shows.…
NEW YORK (Reuters Health) – Intra-arterial fibrinolysis improves outcomes after acute ischemic stroke, a meta-analysis confirms — and although the treatment increases the risk of hemorrhage, that doesn’t…
NEW YORK (Reuters Health) – Urinary dipstick and microscopy testing are not good at finding urinary tract infection when pain is not one of the symptoms, UK researchers…
NEW YORK (Reuters) – In older patients on warfarin therapy, treatment with cotrimoxazole significantly raises the risk of upper gastrointestinal tract hemorrhage, new research shows. The increased hemorrhage…
NEW YORK (Reuters Health) – Octogenarians with heart failure have a higher risk of in-hospital death after defibrillator or pacemaker placement, compared to younger patients, new research shows.…
NEW YORK (Reuters Health) – Adding omega-3 polyunsaturated fatty acids (PUFAs) to dual antiplatelet therapy after stent implantation boosts patients’ platelet response, investigators in Poland report. The P2Y12…
NEW YORK (Reuters Health) – In nondiabetics, high glucose levels signal an increased risk for contrast-induced acute kidney injury during coronary angiography, new research suggests. “Although diabetes is…